Cargando…

The relationship between patient physiology and cancer-specific survival following curative resection of colorectal cancer

The impact of patient physiology on cancer-specific survival is poorly documented. Patient physiology predicted overall, cancer-specific (Physiology Score>30; HR 8.64 (95% CI 3.00–24.92); P=0.0005) and recurrence-free survival (Physiology Score >30; HR 7.44 (95% CI 1.99–27.73); P=0.003) indepe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jenkins, J T, O'Neill, G, Morran, C G
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2007
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359991/ https://www.ncbi.nlm.nih.gov/pubmed/17242695 http://dx.doi.org/10.1038/sj.bjc.6603560

Ejemplares similares

The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer
por: Richards, C H, et al.
Publicado: (2010)

The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer
por: Canna, K, et al.
Publicado: (2005)

Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer
por: Guthrie, G J K, et al.
Publicado: (2013)

The impact of old age on cancer-specific and non-cancer-related survival following elective potentially curative surgery for Dukes A/B colorectal cancer
por: McMillan, D C, et al.
Publicado: (2008)

Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer
por: Moyes, L H, et al.
Publicado: (2009)

C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases
por: Wong, V K H, et al.
Publicado: (2007)

Prognostic value of lymph node ratio and extramural vascular invasion on survival for patients undergoing curative colon cancer resection
por: Parnaby, C N, et al.
Publicado: (2015)

The effect of deprivation and the systemic inflammatory response on outcome following curative resection for colorectal cancer
por: McMillan, D C, et al.
Publicado: (2003)

Development and validation of a nomogram to predict survival after curative resection of nonmetastatic colorectal cancer
por: Hong, Tingting, et al.
Publicado: (2020)

The beneficial effect of palliative resection in metastatic colorectal cancer
por: Park, J H, et al.
Publicado: (2013)

Cost-effectiveness of adjuvant chemotherapy with uracil–tegafur for curatively resected stage III rectal cancer
por: Hisashige, A, et al.
Publicado: (2008)

The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer
por: van Wyk, Hester C, et al.
Publicado: (2016)

Prognostic efficacy of inflammation-based markers in patients with curative colorectal cancer resection
por: Akgül, Özgür, et al.
Publicado: (2017)

The impact of young age on cancer-specific and non-cancer-related survival after surgery for colorectal cancer: 10-year follow-up
por: McMillan, D C, et al.
Publicado: (2009)

Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour
por: Pine, J K, et al.
Publicado: (2015)

Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review
por: Peach, G, et al.
Publicado: (2010)

An individual patient data meta-analysis of adjuvant therapy with uracil–tegafur (UFT) in patients with curatively resected rectal cancer
por: Sakamoto, J, et al.
Publicado: (2007)

The Presence of Mutations in the K-RAS Gene Does Not Affect Survival after Resection of Pulmonary Metastases from Colorectal Cancer
por: Zabaleta, Jon, et al.
Publicado: (2014)

Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer
por: Roxburgh, C S D, et al.
Publicado: (2009)

FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer
por: Bertolini, F, et al.
Publicado: (2011)

A Single Centre Retrospective Evaluation of Laparoscopic Rectal Resection with TME for Rectal Cancer: 5-Year Cancer-Specific Survival
por: Quarati, Raoul, et al.
Publicado: (2011)

Predictors of survival after hepatic resection among patients with colorectal liver metastasis
por: Wang, X, et al.
Publicado: (2007)

Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer
por: Al Murri, A M, et al.
Publicado: (2007)

Initial Experiences of Simultaneous Laparoscopic Resection of Colorectal Cancer and Liver Metastases
por: Hoekstra, L. T., et al.
Publicado: (2012)

An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer
por: Crumley, A B C, et al.
Publicado: (2006)

The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer
por: Lamb, G W A, et al.
Publicado: (2006)

Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies
por: Simmonds, P C, et al.
Publicado: (2006)

Safe liver resection following chemotherapy for colorectal metastases is a matter of timing
por: Welsh, F K S, et al.
Publicado: (2007)

Analysis of the Relationships between Clinicopathologic Factors and Survival in Gallbladder Cancer following Surgical Resection with Curative Intent
por: Yang, Xin-wei, et al.
Publicado: (2012)

Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis
por: Nakamura, H, et al.
Publicado: (2005)

Serum level of miR-142-3p predicts prognostic outcome for colorectal cancer following curative resection
por: Gao, Wencang, et al.
Publicado: (2019)

Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial
por: Nasti, G, et al.
Publicado: (2013)

Cutoff Values of Preoperative s-CEA Levels for Predicting Survivals after Curative Resection of Colorectal Cancer
por: Park, In Ja, et al.
Publicado: (2005)

Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer
por: Gusella, M, et al.
Publicado: (2009)

Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery
por: Lieffers, J R, et al.
Publicado: (2012)

Preoperative neutrophil/lymphocyte ratio predicts overall survival but does not predict recurrence or cancer-specific survival after curative resection of node-positive colorectal cancer
por: Jankova, Lucy, et al.
Publicado: (2013)

Evaluation of a follow-up programme after curative resection for colorectal cancer
por: Howell, J D, et al.
Publicado: (1999)

The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer.
por: Hall, N. R., et al.
Publicado: (1994)

Follow-up of patients with curatively resected colorectal cancer: a practice guideline
por: Figueredo, Alvaro, et al.
Publicado: (2003)

Meta-analysis of colorectal cancer follow-up after potentially curative resection
por: Mokhles, S, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_chrr8irg57cb1feaokfjv6qkh8